Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

panthenol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

9 API Suppliers, 1 USDMF, 4 CEP/COS, 2 JDMF, 1 NDC API, 5 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

125 FDF Dossiers, 14 FDA Orange Book, 67 Europe, 2 Canada, 1 Australia, 6 South Africa, 35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML, SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML, INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL, INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 12 Evonik, 7 Rochem International Inc, 16 SPI Pharma, 12 DKSH, 1 Pharm-RX Chemical, 3 Gangwal Healthcare, 2 Kewpie Corporation, 21 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 5 Pfanstiehl, 42 Kirsch Pharma, 14 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 26 BASF, 1 Bioplus Life Sciences, 2 BioSpectra, 4 CD Formulation, 1 Clariant, 5 Corel Pharma Chem, 2 Esteem Industries, 5 Finar, 15 Gangwal Chemicals, 2 Hayashibara, 1 Ideal Cures, 1 Ingredion Pharma Solutions, 1 Kerry, 1 Keval Exports, 1 Kima Chemical, 5 Lubrizol Life Science Health, 11 Microlex e.U, 2 Nanjing Bold Chemical, 7 Pluviaendo, 25 Roquette, 16 Seppic, 3 Shandong Focus Biotechnology Co., Ltd, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 3 Sigachi Industries, 1 Symrise, 1 The Dow Chemical Company, 2 Valens Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

77 Topical, 77 Parenteral, 56 Thickeners and Stabilizers, 50 Solubilizers, 33 Fillers, Diluents & Binders, 31 Taste Masking, 26 Emulsifying Agents, 22 Film Formers & Plasticizers, 20 Surfactant & Foaming Agents, 19 Direct Compression, 18 Chewable & Orodispersible Aids, 18 Coating Systems & Additives, 14 Rheology Modifiers, 10 Granulation, 10 Lubricants & Glidants, 9 Disintegrants & Superdisintegrants, 8 Co-Processed Excipients, 6 API Stability Enhancers, 6 Controlled & Modified Release, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 11 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 Regulatory FDF Prices

1 Regulatory FDF Prices

MARKET PLACE

45 APIs, 4 FDF Dossiers, 2 EXCIPIENTS

REF. STANDARDS & IMPURITIES

1 EDQM, 8 Others

ANALYTICAL

1 Analytical Methods

1 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	BASF	Germany	BASF SE Ludwigshafen DE	R1-CEP 2006-233 - Rev 03	Dexpanthenol	2021-04-22	Valid	Chemical		761
29/11/2025	Kyowa Pharma Chemical Co Ltd	Japan	Daiichi Fine Chemical Co., Ltd. Takaoka JP	R1-CEP 2006-108 - Rev 00	Dexpanthenol	2013-02-18	Withdrawn by Holder	Chemical	2020-12-15	761

Panthenol

panthenol

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

9 API Suppliers

1 USDMF

4 CEP/COS

2 JDMF

1 NDC API

5 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

125 FDF Dossiers

14 FDA Orange Book

67 Europe

2 Canada

1 Australia

6 South Africa

35 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML

SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML

INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL

INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

12 Evonik

7 Rochem International Inc

16 SPI Pharma

12 DKSH

1 Pharm-RX Chemical

3 Gangwal Healthcare

2 Kewpie Corporation

21 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

5 Pfanstiehl

42 Kirsch Pharma

14 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

26 BASF

1 Bioplus Life Sciences

2 BioSpectra

4 CD Formulation

1 Clariant

5 Corel Pharma Chem

2 Esteem Industries

5 Finar

15 Gangwal Chemicals

2 Hayashibara

1 Ideal Cures

1 Ingredion Pharma Solutions

1 Kerry

1 Keval Exports

1 Kima Chemical

5 Lubrizol Life Science Health

11 Microlex e.U

2 Nanjing Bold Chemical

7 Pluviaendo

25 Roquette

16 Seppic

3 Shandong Focus Biotechnology Co., Ltd

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Shijiazhuang Huaxu Pharmaceutical

3 Sigachi Industries

1 Symrise

1 The Dow Chemical Company

2 Valens Pharmachem

2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

77 Topical

77 Parenteral

56 Thickeners and Stabilizers

50 Solubilizers